NIH Funding Opportunities and Notices for The Week Ending03-06-2020

Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-18-906 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
(NOT-NS-20-023)
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Mental Health
Office of Behavioral and Social Sciences Research

Notice of Special Interest (NOSI): Administrative Supplements to Support Enhancement of Software Tools for Open Science
(NOT-OD-20-073)
National Institutes of Health
John E. Fogarty International Center
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine

Funding Opportunities

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
(PAR-20-111)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): August 11, 2020, February 9, 2021,August 10, 2021,February 9, 2022,August 9, 2022, February 9, 2023 by 5:00 PM local time of applicant organization.
Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD) (U19 Clinical Trial Not Allowed)
(PAR-20-120)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
(PAR-20-122)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): ?August 11, 2020, February 9, 2021, August 10, 2021, February 9, 2022 August 9, 2022, February 9, 2023
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
(PAR-20-123)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below:
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed
(PAR-20-124)
Food and Drug Administration
Application Receipt Date(s): June 1, 2020 by 11:59 PM Eastern Time. May 3, 2021 by 11:59 PM Eastern Time. May 2, 2022 by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late Applications will not be accepted for this FOA
Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)
(PAR-20-125)
National Institute of General Medical Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Office of Research on Women's Health
Application Receipt Date(s): July 24, 2020; June 24, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
NICHD Biomedical Informatic Resource Centers Grants (P41 Clinical Trial Not Allowed)
(PAR-20-126)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply The first standard application due date for this FOA is May 25, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
(PAR-20-127)
National Institute on Deafness and Other Communication Disorders
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed)
(PAS-20-121)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
Advancing Vaccine Science to Improve Tuberculosis Treatment Outcomes for People Living With or Without HIV (R01 Clinical Trial Not Allowed)
(RFA-AI-20-010)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed)
(RFA-AI-20-016)
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed)
(RFA-AR-21-003)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Application Receipt Date(s): August 11, 2020, by 5:00 PM local time of applicant organization. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R01 Clinical Trial Optional)
(RFA-AT-21-001)
National Center for Complementary and Integrative Health
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): July 09, 2020
Exploring the Mechanisms Underlying Modulation of Glymphatic-Lymphatic Systems by Complementary and Integrative Health Approaches (R21 Clinical Trial Optional)
(RFA-AT-21-002)
National Center for Complementary and Integrative Health
National Institute of Dental and Craniofacial Research
Application Receipt Date(s): July 09, 2020
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
(RFA-CA-20-033)
National Cancer Institute
Application Receipt Date(s): August 3, 2020
Urological Epidemiology (UroEpi) Institutional Research Career Development Program (K12 - Independent Clinical Trial Not Allowed)
(RFA-DK-20-001)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): June 18, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Strengthening the Impact of Community Health Workers on the HIV Care Continuum in the US (R01 Clinical Trial Optional)
(RFA-NR-20-002)
National Institute of Nursing Research
National Institute on Drug Abuse
National Institute of Mental Health
Application Receipt Date(s): May 13, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s) Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Research Education Program Grants for CryoEM and CryoET Curriculum Development (R25 Clinical Trial Not Allowed)
(RFA-RM-20-010)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): July 24, 2020. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.